Your order was added!

Show my orders Add more publications

Download & order

Publications

Find out more about our publications here. You can download the publication in the corresponding language as a PDF file or order the print version by mail. We will send you the ordered publications within one week.

Overview Publications My order overview

My order

Quantity

Publication

Language

My shipping address

Shop
Salutation *
*Mandatory fields

The importance of pharmaceutical companies for the regional economy

Show details

The pharmaceutical industry has grown in recent years to become one of the most important pillars in various regions of Switzerland, if not the crucial driver of the regional economy. This study by BAK Economics AG illustrates the various impact channels as exemplified by the biotechnology company Biogen, which is investing around CHF 1.5 billion in the construction of a next-generation biopharmaceutical production facility in Luterbach. This production facility in the canton of Solothurn will directly create some 600 new jobs. Aside from the 400 jobs in biopharmaceutical production, a further 200 will be created in the outsourced areas of building maintenance, cleaning and catering. On the basis of model calculations, BAK reckons that the Biogen plant will result in an additional growth potential of 1.5 to 2.0 percent of the cantonal gross domestic product in 2019, and that the Biogen investment will generate a gross value added of more than CHF 800 million in the whole of Switzerland.

Order

Quantity

The importance of the pharmaceutical industry for Switzerland

Show details

The pharmaceutical industry contributes greatly to the quality of life and prosperity of the Swiss population. Companies invest more than CHF 7 billion annually in research and development in Switzerland. However, the study published today also makes it clear that Switzerland cannot simply rest on its success of recent years.

Order

Quantity

show more publications

About us

Interpharma, the association of Switzerland’s research-based pharmaceutical industry, was founded in Basel in 1933.

Interpharma informs the public about issues that are important to the research-based pharmaceutical industry in Switzerland, including the pharma market in Switzerland, healthcare and biomedical research.

Annual report

Information on our key figures and activities in the financial year 2020

read more

Board and Executive Management

Introducing Interpharma

read more

Vision and Mission

More about the tasks and overriding aims of Interpharma

read more

Contact

Contact us

read more

Media

Latest information and media contacts for media representatives

read more